Correction: Chavda et al. Tirzepatide, a New Era of Dual-Targeted Treatment for Diabetes and Obesity: A Mini-Review. Molecules 2022, 27, 4315
- PMID: 40142172
- PMCID: PMC11944464
- DOI: 10.3390/molecules30061190
Correction: Chavda et al. Tirzepatide, a New Era of Dual-Targeted Treatment for Diabetes and Obesity: A Mini-Review. Molecules 2022, 27, 4315
Abstract
There was an error in the original paper [...].
Erratum for
-
Tirzepatide, a New Era of Dual-Targeted Treatment for Diabetes and Obesity: A Mini-Review.Molecules. 2022 Jul 5;27(13):4315. doi: 10.3390/molecules27134315. Molecules. 2022. PMID: 35807558 Free PMC article. Review.
References
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources